ArticlePDF Available

Evaluating signs of hippocampal neurotoxicity induced by a revisited paradigm of voluntary ethanol consumption in adult male and female Sprague-Dawley rats

Authors:

Abstract

Background Binge alcohol drinking is considered a prominent risk factor for the development of alcohol-use disorders, and could be model in rodents through the standard two-bottle preference choice test. The goal was to recreate an intermittent use of alcohol during 3 consecutive days each week to ascertain its potential impact on hippocampal neurotoxicity (neurogenesis and other neuroplasticity markers), and including sex as a biological variable, given the well-known sex differences in alcohol consumption. Methods Ethanol access was granted to adult Sprague–Dawley rats for 3 consecutive days per week, followed by 4 days of withdrawal, during 6 weeks, mimicking the most common pattern of intake in people, drinking over the weekends in an intensive manner. Hippocampal samples were collected to evaluate signs of neurotoxicity. Results Female rats consumed significantly more ethanol than males, although intake did not escalate over time. Ethanol preference levels remained below 40% over time and did not differ between sexes. Moderate signs of ethanol neurotoxicity were observed in hippocampus at the level of decreased neuronal progenitors (NeuroD + cells), and these effects were independent of sex. No other signs of neurotoxicity were induced by ethanol voluntary consumption when measured through several key cell fate markers (i.e., FADD, Cyt c, Cdk5, NF-L) by western blot analysis. Conclusions Overall, the present results suggest that even though we modeled a situation where no escalation in ethanol intake occurred across time, mild signs of neurotoxicity emerged, suggesting that even the use of ethanol during adulthood in a recreational way could lead to certain brain harm.
Vol.:(0123456789)
1 3
Pharmacological Reports
https://doi.org/10.1007/s43440-023-00464-6
ARTICLE
Evaluating signs ofhippocampal neurotoxicity induced byarevisited
paradigm ofvoluntary ethanol consumption inadult male andfemale
Sprague‑Dawley rats
CarlesColom‑Rocha1,2· CristianBis‑Humbert1,2,3· M.JuliaGarcía‑Fuster1,2
Received: 15 November 2022 / Revised: 7 February 2023 / Accepted: 8 February 2023
© The Author(s) 2023
Abstract
Background Binge alcohol drinking is considered a prominent risk factor for the development of alcohol-use disorders, and
could be model in rodents through the standard two-bottle preference choice test. The goal was to recreate an intermittent
use of alcohol during 3 consecutive days each week to ascertain its potential impact on hippocampal neurotoxicity (neuro-
genesis and other neuroplasticity markers), and including sex as a biological variable, given the well-known sex differences
in alcohol consumption.
Methods Ethanol access was granted to adult Sprague–Dawley rats for 3 consecutive days per week, followed by 4days
of withdrawal, during 6weeks, mimicking the most common pattern of intake in people, drinking over the weekends in an
intensive manner. Hippocampal samples were collected to evaluate signs of neurotoxicity.
Results Female rats consumed significantly more ethanol than males, although intake did not escalate over time. Ethanol
preference levels remained below 40% over time and did not differ between sexes. Moderate signs of ethanol neurotoxicity
were observed in hippocampus at the level of decreased neuronal progenitors (NeuroD + cells), and these effects were inde-
pendent of sex. No other signs of neurotoxicity were induced by ethanol voluntary consumption when measured through
several key cell fate markers (i.e., FADD, Cyt c, Cdk5, NF-L) by western blot analysis.
Conclusions Overall, the present results suggest that even though we modeled a situation where no escalation in ethanol
intake occurred across time, mild signs of neurotoxicity emerged, suggesting that even the use of ethanol during adulthood
in a recreational way could lead to certain brain harm.
Keywords Alcohol voluntary drinking· Sex differences· Hippocampus· Neurogenesis· Rat
Introduction
Alcohol is the legal drug most consumed at world level; in
2020, the last National Survey on Drug Use and Health [1]
reported that 50% of people in the USA, ages 12 or older,
used alcohol in the past month, and from those, around 44%
were classified as binge drinkers and 13% as heavy drinkers.
Binge drinking, defined by the National Institute on Alcohol
Abuse and Alcoholism (NIAAA) as an enduring period of
observable behavioral intoxication that brings blood alcohol
concentration to 0.08g percent (or 80mg%) or above (e.g., 5
or more drinks for males or 4 or more drinks for females in
about 2h), is a prominent risk factor for later development
of alcohol-use disorders (e.g., [2]).
At the preclinical level, binge modeling of ethanol drink-
ing across laboratories has been proven challenging in terms
of achieving comparable intoxication levels (as measured
by high blood ethanol concentrations), since when provided
in a 24-h span, rodents distribute their intake throughout
the day. Distinctive paradigms have been characterized for
adult rodents utilizing variations of the standard two-bottle
preference choice test, which initially allowed continuous
unlimited access to one bottle containing an ethanol solution
(i.e., [3]; and hundreds of publications afterwards), to then
* M. Julia García-Fuster
j.garcia@uib.es
1 IUNICS, University oftheBalearic Islands, Cra. de
Valldemossa Km 7.5, 07122Palma, Spain
2 Health Research Institute oftheBalearic Islands (IdISBa),
Palma, Spain
3 Present Address: Psychobiology ofDrug Addiction,
Neurocentre Magendie, INSERM U1215, Bordeaux, France
C.Colom-Rocha et al.
1 3
limit its scheduling to better mimic human alcohol intake
(i.e., reviewed by [4, 5]). Providing an intermittent access to
a bottle with ethanol (i.e., 10–20% solution range) models a
progressive increase in intake across time following cycles
of exposure and drug removal, with increased preference
ratios when ethanol is reintroduced (reviewed by [4, 5]). The
most commonly used schedule allows unlimited access to
rats for periods of 24h on alternate days (Mondays, Wednes-
days and Fridays), creating multiple 24-h short-withdrawal
periods in between ethanol drinking sessions, which have
proven to lead to severe consequences (i.e., kindling effect
[6, 7] and/or negative affect [8]). Over a period comprising
several weeks, rats show a progressive increase in voluntary
ethanol intake, modeling the development of an addictive-
like phenotype (e.g., [9]; reviewed by [4, 5]). Other inter-
mittent models are based on given access to ethanol only
for a limited time each day (e.g., 4h per day during 4 con-
secutive days a week [10]). Moreover, additional schedules
mimicking the development of addictive-like features, either
allowing continuous access to ethanol during several weeks
or giving access to ethanol at night when rats are active
“drinking in the dark” model (reviewed by [4]), have been
extensively utilized leading to multiple publications.
In the present study, however, we decided to revisit the
most used paradigm that allows access to ethanol for 3 non-
consecutive days a week (e.g., Monday, Wednesday and Fri-
day) with alternate 24-h periods of access and/or withdrawal,
to explore the response of a continuous 3-day access (i.e.,
72h of unlimited access) followed by a period of 4days of
withdrawal, mimicking the most common pattern of intake
in people, drinking over the weekends in a voluntary man-
ner. This pattern of consumption, although it might not nec-
essarily lead to intoxication and/or alcohol-use disorder, it
could still be used as a model in which to study sex-specific
neuronal adaptations and/or complications. This is particu-
larly relevant given the well-known differential influence of
sex when modeling addiction in animals (e.g., [11]); female
rats of many strains and ages (adolescent and/or adult) drink
more alcohol than their male counterparts (e.g., [1214]).
Also, ethanol is predominantly harmful in hippocampus
(both structural and function-dependent; e.g., [1518]), and
there are well-known sex differences in hippocampal dam-
age following alcohol use (e.g., [19, 20]). Therefore, our
goal was to revisit and recreate an intermittent use of alcohol
in rats of both sexes, with greater behavioral translation to
the pattern observed in humans, in which to ascertain the
potential impact on hippocampal neurotoxicity.
In this context, signs of hippocampal neurotoxicity were
evaluated at different levels. The negative effects of ethanol
on impairing the novel generation of adult neurons in hip-
pocampus are well known (i.e., for its consequences on the
different stages of adult neurogenesis see [21]; reviewed by
[22]). Prior studies reported sex differences in hippocampal
damage (e.g., [19]), including changes in the regulation of
adult neurogenesis following ethanol use (e.g., [19, 20]),
and other sex-specific differential neurotoxic events (e.g.,
miRNAs expression [23]; microglia number and reactiv-
ity [24]). However, there is still scarce knowledge on the
magnitude and/or direction of the events taking place in the
hippocampus of female rodents following ethanol exposure.
In this context, we compared the potential sex differences in
the regulation of the initial stages of adult neurogenesis (i.e.,
cell proliferation and early neuronal survival). Moreover,
to deepen our understanding on the sex-related neurotoxic
events that might be taking place in this brain region, we
selected some key molecular markers, with certain links to
the regulation of adult hippocampal neurogenesis that were
previously characterized for adult male rodents in the con-
text of other drugs of abuse. For example, the dysregulation
of Fas-Associated protein with Death Domain (FADD), a
key cell fate player that could balance cell death vs. plas-
ticity events (reviewed by [25, 26]), paralleled decreased
levels of cell proliferation in hippocampus following cocaine
exposure [27], suggestive of neurotoxic events in this brain
region in male rats. We also studied another marker of the
apoptotic pathway (Cytochrome c, Cty c)whose expres-
sion was altered by drugs of abuse (i.e., cocaine, MDMA)
in hippocampus in conjunction with FADD [28, 29]. Also,
Cyclin-dependent kinase-5 (Cdk5)was evaluated since is
key in the regulation of neurogenesis [30] and was shown
to be modulated in parallel to FADD in hippocampus (see
[31]). Finally, the potential structural damage of ethanol was
evaluated at the level of neurofilament proteins (e.g., NF-L)
as certain drugs of abuse induced neurotoxicity in male rats
by decreasing its hippocampal content (e.g., [29]); it was
found hyperphosphorylated in hippocampus in response to
ethanol toxicity [32], and its circulating levels were altered
in heavy drinking in association with lower gray matter
thickness [33]. Exploring these molecular events will give
us an idea of which pathways and/or events should be further
explored in the context of ethanol toxicity in hippocampus
for each sex.
Materials andmethods
Animals
A total of 42 adult Sprague-Dawley rats (21 males and 21
females) bred in the animal facility at the University of
the Balearic Islands were used in this study. During the
experimental procedures, rats were housed individually in
standard cages following a 12-h light/dark schedule (lights
on at 8:00AM) in a climate-controlled room (22°C, 70%
humidity) and with unlimited access to a standard diet and
water. Rats were given at least 1week to acclimatize to
Evaluating signs ofhippocampal neurotoxicity induced byarevisited paradigm ofvoluntary…
1 3
the housing conditions and the handling prior to the actual
experiments, which were performed during the light period
(between 10:00 and 12:00h). All procedures complied with
the ARRIVE Guidelines [34], the EU Directive 2010/63/
EU and the Spanish Royal Decree 53/2013 for animal
experiments, and were approved both by the Local Bioethi-
cal Committee (CEEA 100/10/18) and the Regional Gov-
ernment (Exp.: 2018/14/AEXP). All efforts were made to
minimize the number of rats used and their suffering. In this
context, and to prevent the induction of unnecessary stress in
female rats during the experimental procedure, the specific
stages of the estrous cycle were not examined. This decision
was based on the fact that prior studies suggested that the
estrous cycle stage might not be a significant player in the
amount of ethanol consumption for female rats (e.g., [35]),
but mainly because the cyclicity of females was not part of
our research question (see [36]).
Intermittent access to20% ethanol inatwo‑bottle
choice test
Rats of each sex were randomly allocated into two exper-
imental groups (Control, n = 10 and Ethanol, n = 11 per
sex; see Fig.1a) and were exposed to two bottles with
fluids during 6 consecutive weeks. Each week, rats from
the ethanol groups were given unlimited voluntary access
to ethanol (20% ethanol vs. water) during 3 consecutive
days (i.e., every Tuesdays, Wednesdays and Thursdays)
followed by a period of 4days of withdrawal (all rats
had access to 2 bottles of water). Rats from the control
groups were always exposed to two bottles of water. Each
rat was exposed to a total of 18 ethanol (or control) ses-
sions during the 6-week procedure. The placement of the
ethanol bottle was alternated daily to account for side
preferences and bottles were weighed every morning dur-
ing the 3days of ethanol access. Total fluid intake (sum
of both bottles in ml) and the amount of water and/or
ethanol consumed (in ml) was recorded on each session
day. Ethanol preference was calculated as the amount of
ethanol consumed divided by total fluid intake and multi-
plied by 100 (% values). Weights were monitored weekly
(D1 of each week) throughout the course of 6weeks as
detailed in Fig.1a, and were used to calculate the amount
of ethanol consumed (g/kg) daily and cumulative (i.e.,
ethanol load throughout the whole experimental proce-
dure). Results are expressed as daily consumption, aver-
age consumption per week and average consumption dur-
ing the 18 sessions.
Fig. 1 Experimental design. a Sprague-Dawley rats were exposed
during 6 consecutive weeks to a weekly schedule consisting of a
3-day continued voluntary ethanol access (two-bottle choice: 20%
ethanol vs. water; D1–D3) followed by a 4-day withdrawal period
(two bottles of water). Rats were killed on the last day of ethanol
exposure on week 6 (D38). b Changes in body weight across weeks
(g). Groups of treatment: Control-male (n = 10); Ethanol-male
(n = 11); Control-female (n = 10); Ethanol-female (n = 11). Columns
represent mean ± SEM of change in body weight (g). Individual sym-
bols are shown for each rat. #p < 0.05 when comparing the effect of
sex (female vs. male rats; three-way RM ANOVA)
C.Colom-Rocha et al.
1 3
Immunohistochemistry
Rats were killed by rapid decapitation on the last session/day
of week 6 (D38; see Fig.1a) and the left half-brain was snap-
frozen with 30°C isopentane (Panreac Química, Barcelona,
Spain, cat #143501) and stored at 80°C to latter quantify
hippocampal neural progenitors by immunohistochemistry
at specific periods of regulation (i.e., cell proliferation with
Ki-67 and early neuronal survival with NeuroD). Tissue was
cryostat-cut (30µm sections) and slide-mounted throughout
the whole hippocampal extent ( 1.72 to 6.80mm from
Bregma) in 3 series containing the most anterior, the middle
part and the most posterior part of this region as described
in detail before [3739]. For each marker, experiments were
performed in 1 slide per rat containing 8 tissue-sections from
the middle portion of the hippocampus that were post-fixed
in 4% paraformaldehyde (Merck, Darmstadt, Germany, cat
#76240). Then, sections were exposed to several steps, such
as epitope retrieval in 10% sodium citrate dihydrate (Thermo
Fisher Scientific, Waltham, MA, USA, cat #BP327-1) pH
6.0 at 90°C for 1h, 0.3% peroxidase solution (Thermo
Fisher Scientific, cat #426000010) and BSA blocking
(Merck, cat #A7906) before an overnight incubation with
rabbit anti-Ki-67 (1:20000) (provided by Drs. Huda Akil
and Stanley J. Watson, University of Michigan, MI, USA,
cat #B7) or goat anti-NeuroD (1:25000; Santa Cruz Biotech-
nology, CA, USA, cat #sc-1084). The next steps included
a series of sequential incubations, first with the second-
ary antibody (biotinylated anti-rabbit or anti-goat, 1:1000
respectively, Vector Laboratories, CA, USA, cat #BA-1000
and BA-5000 respectively), followed by the Avidin/Biotin
complex (Vectastain Elite ABC kit; Vector Laboratories,
cat #PK-6100), and the chromogen 3,3’-diaminobenzidine
(DAB; Merck, cat #D8001) for signal detection(for NeuroD
with nickel chloride; Merck, cat #339350). Tissue for Ki-67
quantification was counterstained with cresyl violet (Thermo
Fisher Scientific, cat #405760100). Finally, sections were
dehydrated in graded alcohols, immersed in xylene (Shar-
lab, Barcelona, Spain, cat #XI0052) and cover-slipped with
Permount® (Thermo Fisher Scientific, cat #SP15-500). Pos-
itive cells were quantified in the dentate gryus of 8 sections/
rat by an experimenter blind to the treatment groups with a
Leica DMR light microscope (63 × objective lens). The total
number of positive cells is represented in relation to the %
number of cells present in control-male rats.
Western blot
Hippocampal cell fate markers were evaluated by Western
blot analysis. To do so, total homogenates were prepared
from the right hippocampus as previously described in detail
before (see [28, 29]). Brain proteins (40μg; protein amount
assessed by BCA, Thermo Fisher Scientific, cat #23225)
were separated by electrophoresis on 10–15% SDS-PAGE
minigels (Bio-Rad Laboratories, Hercules, CA, USA) and
transferred (110V, during 2h 30min) to nitrocellulose
membranes that were incubated with appropriate primary
antibody whose vendors and dilution conditions were the
following: (1) Santa Cruz Biotechnology (CA, USA): anti-
FADD (H-181) (1:2500; cat #sc-5559); (2) BD Biosciences
(CA, USA): anti-Cyt c(1:5000; cat #556433); (3) Lab
Vision Corporation (CA, USA): anti-Cdk5 (DC17) (1:1000;
cat #DC17); and (4) Sigma-Aldrich (MO, USA): anti-NF-
L (N5139) (1:1000; cat #5139NR4), anti-β-actin (clone
AC-15) (1:10000; cat #A1978). Following incubation with
the appropriate secondary antibody (anti-rabbit or -mouse
IgG linked to horseradish peroxidase; 1:5000; Cell Signal-
ing; cat #7074 and 7076, respectively), the immunoreactivity
of selected proteins was detected by ECL reagents (Amer-
sham, Buckinghamshire, UK) and signal of bound antibody
was visualized with autoradiographic films (Amersham ECL
Hyperfilm). Each band of interest was quantified by densito-
metric scanning (GS-800 Imaging Calibrated Densitometer,
Bio-Rad), and percent changes in immunoreactivity for each
marker were calculated for each rat with respect to control-
male samples (100%) in various gels (each sample was run
at least 2–3 times in different gels), and the mean value was
used as a final estimate. Data were not normalized to any
protein, since β-actin analysis served as a loading control
(i.e., its content was not altered by any treatment conditions).
Data statistical analyses
GraphPad Prism, Version 9.5 (GraphPad Software, USA)
was used to analyze and plot all graphs following the guide-
lines in experimental pharmacology for displaying data
and statistical methods [40]. Results are reported as mean
values ± standard error of the mean (SEM), and individual
symbols for each rat are shown within bar graphs. Paramet-
ric tests were used for statistical comparisons, since assump-
tions for normality of data distribution and homogeneity of
variance (in case of analysis of variance) were met (i.e.,
D’Agostino-Pearson normality test). Three-way repeated-
measure (RM) ANOVAs were performed when analyzing
potential changes in body weight (g), total fluid (sum of
liquid consumed from both bottles independently of its
contents and expressed in ml) and water (volume consumed
from a single water bottle through the course of the experi-
mental procedures and expressed in ml). The independent
variables of study were Sex, Bottle Choice (Ethanol vs.
Water) and Time of Analysis (Day or Week). When meas-
uring ethanol preference (%) and ethanol dose consumed (g/
kg) data were analyzed with two-way RM ANOVAs (inde-
pendent variables: Sex and Time of Analysis), since all rats
were exposed to the choice of one ethanol bottle. Cumulative
ethanol load was compared between male and female rats
Evaluating signs ofhippocampal neurotoxicity induced byarevisited paradigm ofvoluntary…
1 3
with an unpaired two-tailed t-test. Finally, the regulation of
hippocampal markers of induced neurotoxicity (i.e., neural
progenitors and/or cell fate markers) was performed with a
two-way ANOVA (independent variables: Sex and Experi-
mental Group). Individual values were normalized to control
male rats, to estimate the % magnitude of change. Tukey's
or Sidak's multiple comparisons tests were performed for
post hoc pair-wise statistical comparisons when appropriate.
The level of significance was set at p ≤ 0.05. Interactions
among variables were only reported when relevant and/or
significant.
Results
All datasets generated during and/or analyzed during the
current study are available from the corresponding author
on reasonable request. Moreover, a table with full statistical
analysis is included as Supplementary Materials.
No changes inbody weight byethanol voluntary
consumption
The impact of voluntary ethanol consumption on weekly
body weight was analyzed (see Supplementary TableS1).
While there was no effect of Bottle of Choice (F1,38 = 0.16,
p = 0.692), the expected significant effects of Sex
(F1,38 = 281.8, ###p < 0.001; Fig.1b) and Time of Analy-
sis (F6,228 = 323.6, p < 0.001) were observed (i.e., increased
weight in male vs. female rats, and progressive body weight
gain over time during adulthood).
Intermittent access to20% ethanol inatwo‑bottle
choice test for3 consecutive days
When evaluating how the procedure might have affected
daily total fluid intake (ml) (a total of 18days; 3days/
week), the results showed that there were no significant
effects of Bottle Choice (F1,38 = 1.48, p = 0.231) or Sex
(F1,38 = 0.14, p = 0.709), but a significant effect of Time of
Analysis (F17,646 = 25.63, p < 0.001) (see Fig.2a and Sup-
plementary TableS1); results that could also be represented
as the average 3-day consumption in a given week (see
Fig.2b). When calculating the average daily intake across
all 18days, male rats consumed an average of 45.9ml of
daily fluid, while female rats consumed 44.8ml, and these
total volumes were not affected by the fact that rats had or
not access to ethanol (Fig.2c and Supplementary TableS1).
However, for water intake, the results showed a significant
effect of Bottle Choice (F1,38 = 19.84, p < 0.001) and Time
of Analysis (F17,646 = 20.49, p < 0.001), but no effect of Sex
(F1,38 = 0.35, p = 0.555) (see Fig.2d); results that could also
be represented as the average 3-day consumption in a given
week (see Fig.2e). Rats that had access to an ethanol bot-
tle drank more water than those with no access (i.e., water
intake was calculated as the average of both water bottles),
as represented by the daily intake averaged across all 18days
(see statistics analysis in Supplementary TableS1). While
male and female control rats consumed similar amounts of
water (an average of 26.8 vs. 25.8ml per day, respectively),
rats with access to one bottle of ethanol drank, in aver-
age, more water every day (males: + 9.7ml, ***p < 0.001;
females: + 7.2ml, *p = 0.023 vs. controls; Fig.2f) as rep-
resented by the significant effect of Bottle of Choice (Sup-
plementary TableS1).
When calculating ethanol preference (%) for rats exposed
to both liquids, the results showed that there was no sig-
nificant effect of Sex (F1,20 = 0.74, p = 0.400), but a signifi-
cant effect of Time of Analysis (F17,340 = 3.54, p < 0.001)
(see Fig.2g and Supplementary TableS1). The fluctua-
tions observed across days dissipated when results were
represented as the average 3-days consumption in a given
week (F5,100 = 2.02, p = 0.083; see Fig.2h, Supplementary
TableS1). In general, no sex differences were observed
in ethanol preference, with male rats showing an average
preference of 37.0% while females showed a preference of
39.2% (Fig.2i). Although the preference for ethanol was
the same for both sexes, when evaluating the dose of etha-
nol consumed (g/kg), a significant effect of Sex displayed
in the statistical analysis (F1,20 = 7.82 #p = 0.011; Fig.2j),
together with an effect of Time of Analysis (F17,340 = 13.07,
p < 0.001); results also detected when the average 3-day con-
sumption in a given week was represented (see Fig.2k, Sup-
plementary TableS1). Female rats showed a higher dose of
ethanol consumed (12.2g/kg) when compared to male rats
(8.0g/kg), with a mean increase of 4.2g/kg (*p = 0.011 vs.
male rats; Fig.2l, Supplementary TableS1). Interestingly,
when calculating the cumulative ethanol load across all
experimental days, female rats consumed a total of 219.2g/
kg as compared to males that consumed only 143.8g/kg
(t = 2.80, df = 20, p = 0.011; data not shown in figures).
Decreased survival ofneural progenitors byethanol
voluntary consumption asasign ofethanol‑induced
neurotoxicity
The number of Ki-67 + cells was used to measure poten-
tial changes in cell proliferation for all groups as compared
to control-male rats and expressed as % of its mean value
(700 ± 102 Ki-67 + cells; expected number of cells for male
rats of this age [37, 39]). The results showed no significant
effects of Bottle Choice (F1,36 = 0.01, p = 0.925) or Sex
(F1,36 = 0.24, p = 0.627) (see Fig. 3a, and Supplementary
TableS1). As for NeuroD, the mean number of + cells in
control-male rats (used to calculate the % changes for the
rest of the groups) were 6616 ± 246 NeuroD + cells, also
C.Colom-Rocha et al.
1 3
in line with prior data in male rats of this age [37, 39]. In
this case, ethanol access decreased the survival of neu-
ral progenitors, as measured through the number of Neu-
roD + cells, and as observed by the significant effect of
Bottle Choice (F1,37 = 8.98, **p = 0.005); rats with access
to ethanol displayed an average of 22.7% lower Neu-
roD + cells when compared to control rats, independently
of sex (Fig.3b, Supplementary TableS1). This effect was
Evaluating signs ofhippocampal neurotoxicity induced byarevisited paradigm ofvoluntary…
1 3
observed for each sex when analyzed separately (male rats:
-26%, *p = 0.042; female rats: -19%, *p = 0.05; see Fig.3b,
Supplementary TableS1). Moreover, female rats showed
lower NeuroD + cells (a general drop of 15.5%) than male
rats as observed by the significant effect of Sex (F1,37 = 4.19,
#p = 0.048) (Fig.3b). Correlation analysis were performed
between the different parameters of ethanol consumption
(i.e., average intake, preference and even with cumulative
intake across all days) and the number of hippocampal Neu-
roD + cells; however, none of these variables were predictive
of the later changes observed (data not shown).
Besides, no other signs of neurotoxicity were induced
by ethanol voluntary consumption during adulthood when
measured through several key cell fate markers (i.e., FADD,
Cyt c, Cdk5, NF-L) by western blot analysis at the specific
time-point of consideration (see Fig.3c-f, Supplementary
TableS1). The only significant change observed through the
two-way ANOVAs performedwas the significant effect of
sex for FADD (F1,38 = 5.84, #p = 0.021; + 16.7% more FADD
content for female adult rats independently of Bottle Choice;
see Fig.3c). β-actin was quantitated and used as a loading
control as it was not altered by any treatment conditions
(see Fig.3g).
Discussion
The main results showed moderate signs of ethanol neuro-
toxicity in hippocampus at the level of decreased neuronal
progenitors (NeuroD + cells), effects that were independent
of sex. Overall, the present results suggested that even in
a situation where no escalation of ethanol intake occurred
across time (a pattern mimicking a potential recreational use
of ethanol in people), certain signs of neurotoxicity emerged,
suggesting that sporadic ethanol use could still induce cer-
tain consequences in adult rats.
Our results aligned with several prior studies report-
ing that adult female rats, when given access to ethanol,
consumed more (in g/kg), than their male counterparts (e.g.,
[1214, 35],). In fact, the absolute volume of ethanol con-
sumption did not different between sexes, however, given the
smaller body weight of adult females, their total consump-
tion in a g/kg basis was higher (around 4.2g/kg higher per
day in average). However, in comparison with other intermit-
tent paradigms of ethanol accessibility (i.e., 24-h periods of
access on alternate days of the week), the schedule followed
in the present study (ethanol access continuously for 3days
a week followed by 4days of withdrawal during 6weeks)
did not lead to a temporal increase in intake, neither for
male nor forfemale rats. In our particular conditions, the
range of intake (lowest and highest value) among individual
rats from each group fluctuated between 5.5 and 12.8g/kg
(mean value of 8.0g/kg) for adult males, and between 6.6
and 20.1g/kg (mean value of 12.2g/kg) for adult female
rats, which are considered moderate to large doses of ethanol
(reviewed by [4]). This differs from prior data describing
that Sprague-Dawley rats consume low to moderate levels
of ethanol and achieve lower ethanol preference rates than
other strains (reviewed by [5]). That seems to be one of the
reasons why the majority of studies reported in the literature
were done in Long-Evan or Wistar rats, although escalation
in ethanol intake has been reported for all strains, including
Sprague-Dawley (reviewed by [5]). Moreover, many studies
have revealed that not only strain, but also many other fac-
tors could affect the behavioral results, such as age, sex and
particular environmental conditions (e.g., number of avail-
able bottles, ethanol concentration and temporal accessibil-
ity, etc.; reviewed by [41]), and could justify the lack of
escalation in ethanol intake (g/kg) and/or in ethanol prefer-
ence observed with the current paradigm.
In terms of ethanol preference across time, our results
reported no significant differences by sex, with male rats
showing an average preference of 37.0% while females
showed a preference of 39.2%. The preference was below
50% since rats with access to ethanol drank more water
than ethanol, although the total amount of fluid intake
did not change when compared to their respective control
group (i.e., comparing rats exposed to two-water bottles
vs. rats given unlimited access to ethanol). Still, these
levels of preference seemed comparably higher to others
previously reported in the literature showing ethanol pref-
erences starting around 15% on day 1, and then escalating
up to 35–40% following several weeks of exposure (e.g.,
[9]). Our results reported similar amounts of ethanol con-
sumption every week (no drop in consumption observed
with time), but no escalation in preference over time, sug-
gesting no progression into an addictive-like phenotype.
Contrary, we could argue that in our particular experimen-
tal conditions, and right from the start of the procedure
(week 1 and onward), rats showed goodpreference levels
for ethanol, in line with the high values of intake described
Fig. 2 Intermittent access to 20% ethanol in a two-bottle choice
test for 3 consecutive days. a–c Total fluid (ml) and d–f Water (ml)
intake daily (a–d), weekly (b–e) and expressed as the 18days over-
all average (c–f). Groups of treatment: Control-male (n = 10); Etha-
nol-male (n = 11); Control-female (n = 10); Ethanol-female (n = 11).
Columns represent mean ± SEM of the amount of liquid consumed
in ml. Individual symbols are shown for each rat. Three-way RM
ANOVAs showed no significant effects of Bottle Choice or Sex. g–i
Ethanol preference (%) and j–l Ethanol (g/kg) consumption daily
(g–j), weekly (h–k) and expressed as the 18 days overall average
(i–l). Groups of treatment: Ethanol-male (n = 11); Ethanol-female
(n = 11). Columns represent mean ± SEM of the preference for etha-
nol (expressed as a % value) or ethanol dose consumed (g/kg). Indi-
vidual symbols are shown for each rat. #p < 0.05 when comparing the
general effect of sex (two-way repeated-measures ANOVA); *p < 0.05
when comparing the dose consumed by female rats vs. male rats (Stu-
dent’s t-test)
C.Colom-Rocha et al.
1 3
above, and as compared to prior studies (reviewed by [4,
5]), and maybe representing steady celling values prevent-
ing further escalation. In fact, we propose that this pattern
of consumption might be mimicking the recreational use
of ethanol during weekends in people. Overall, the present
paradigm did not show escalation of ethanol intake, but
it reproduced high levels of consumption, mimicking a
common paradigm of intake for most adult individuals, in
which to evaluate potential signs of neurotoxicity induced
by ethanol in hippocampus.
Fig. 3 Evaluating signs of ethanol-induced neurotoxicity in hip-
pocampus. Quantitative analysis of a Ki-67 and b NeuroD + cells in
the left dentate gyrus of the hippocampus by immunohistochemis-
try or of c FADD, d Cytochrome c (Cyt c) e Cdk5, f NF-L and g
β-actin protein content by western blot analysis in the hippocampus
of male and female rats exposed to the two-bottle choice test (Con-
trol vs. Ethanol) on D38. Groups of treatment: Control-male (n = 10);
Ethanol-male (n = 11); Control-female (n = 10); Ethanol-female
(n = 11). Columns represent mean ± SEM of the number of + cells
quantified in 8 sections from the middle part of the hippocampus
and expressed as % change vs. control-male rats or of n experiments
per group and expressed as a percentage of Control-male-treated
rats. Individual symbols are shown for each rat. Two-way ANOVAs
evaluating the potential effects of Bottle Choice (ethanol vs. water)
and Sex. #p < 0.05 when comparing the general effect of sex and
**p < 0.01 when comparing the effects of having access to a bottle
with ethanol vs. control (general effect independently of sex). Bottom
panels: representative images showing individual Ki-67 (brown labe-
ling in the blue granular layer) and NeuroD (dark blue labeling in the
blue granular layer) cells taken with a light microscope (40 × objec-
tive lens) or representative immunoblots depicting labeling of FADD,
Cyt c, Cdk5, NF-L and β-actin are shown for each set of experiments.
Other representative images for Ki-67 and NeuroD labeling and/or
full immunoblots from which images were taken could be found in
Supplementary Materials
Evaluating signs ofhippocampal neurotoxicity induced byarevisited paradigm ofvoluntary…
1 3
Overall, the neurochemical results showed a moderate
impact of ethanol on the markers evaluated in hippocampus.
In particular, both male and female rats exposed to ethanol
intermittently during 6weeks presented lower hippocampal
NeuroD + cells, a sign of decreased survival rate of neural
progenitors (immature neurons). These results align with
prior studies reporting damaging effects of ethanol on sev-
eral stages of adult neurogenesis, including neuronal pro-
genitors (e.g., [21]; reviewed by [22]), to describe a similar
impact but following a distinct scheduling and including
both sexes. Contrarily to other studies that reported sex dif-
ferences in the regulation of hippocampal neurogenesis fol-
lowing ethanol use (e.g., [19, 20]), the present data showed
similar changes on NeuroD for bothsexes, even though
females consumed more ethanol (in g/kg). This was inter-
esting given the basal differences observed in Neuro + cells,
having female rats lower neuronal progenitors as compared
to male rats. However, independent of these basal differ-
ences, ethanol exposure affected both sexes similarly. This
goes along with the sex effects priory reported in the differ-
ent stages of hippocampal neurogenesis in the literature [42,
43], and in particular with the reported slower hippocampal
neuronal maturation in females compared to males [43, 44].
In line with these baseline sex disparities, adult female
rats also showed higher hippocampal FADD protein content
than males, suggesting differences in baseline hippocampal
neurotoxicity rates in line with their, just reported, lower
NeuroD levels. Interestingly, FADD and/or the rest of the
potential markers evaluated (Cyt c, Cdk5, NF-L) showed
no signs of induced toxicity by ethanol exposure that could
accompany the observed moderate decreased number of
neuronal progenitors, even though prior studies have paired
decreases in NeuroD with increases in FADD content but
following cocaine exposure [27]. Although no prior stud-
ies have evaluated hippocampal FADD regulation following
ethanol consumption invivo, indications of ethanol-induced
apoptosis through Fas-mediated pathways were described
in several invitro lines of human liver adenocarcinoma
cells [45, 46]. Considering the present results, probably
the amount of ethanol exposure was not sufficient to induce
changes in FADD protein. Alternatively, the expected ini-
tial acute change might have adapted following a 6-week
repeated ethanol exposure. These explanations might also
justify the lack of effects on the other markers evaluated in
hippocampus by ethanol exposure. For example, no changes
were observed in Cdk5 regulation, although prior studies
suggested that ethanol exposure resulted in Cdk5 overactiva-
tion in cortex and cerebellum [47], as well as in increased
levels of Cdk5 and its activator p25 in hippocampus. These
prior experiments suggested that interfering with this path-
way might serve as a potential therapeutic approach to pre-
vent ethanol-induced neurotoxicity in the brain [48], and
although our results did not find Cdk5 altered at the end of
the procedure, maybe it still might be regulated during etha-
nol consumption. Similarly, we found no signs of neurotox-
icity as measured by NF-L protein content in hippocampus,
though it was found hyperphosphorylated in hippocampus
in response to ethanol toxicity [32], and other drugs of abuse
(i.e., opiates/opioids and MDMA) decreased its content, pro-
posing NF-L as a marker of structural damage to particular
brain regions [29, 49].
In conjunction, the present results demonstrated a mod-
erate neurotoxic effect of ethanol exposure as observed by
decreased NeuroD + cells in the dentate gyrus of male and
female rats, without any other ethanol-evoked changes (i.e.,
number of Ki-67 + cells or protein contents of FADD, Cyt
c, Cdk5, NF-L). The discrepancies with prior reports that
suggested signs of neurotoxicity through the dysregulation
of these markers by ethanol exposure could be due to dif-
ferent experimental conditions, including the paradigm of
ethanol used, the specific time of evaluation, and/or whether
experiments were performed invitro or invivo, among other
factors. Therefore, our pool of data is limited by how the
experimental procedures were designed and could only be
discussed in that context, yet presented relevant results while
including sex as a biological variable. Other complementary
experiments, both behavioral and neurochemical, would be
required to demonstrate other signs of neurotoxicity, besides
our moderate changes, and thus our conclusions are limited
to the current design which particularly studied the regu-
lation of the proposed markers on a single time-point of
analysis at the end of the experiment.
In conclusion, this study sheds light on some of the poten-
tial negative consequences induced by a common pattern of
ethanol consumption during adulthood, with no apparent
signs of increased intake and/or changes in ethanol prefer-
ence, but with certain signs of moderate neurotoxicity. Over-
all, our data suggest that the consumption of ethanol during
adulthood, although at a recreational level, could also lead
to certain brain harm.
Supplementary Information The online version contains supplemen-
tary material available at https:// doi. org/ 10. 1007/ s43440- 023- 00464-6.
Acknowledgements The authors would like to thank Drs. Huda Akil
and Stanley J. Watson (University of Michigan, Ann Arbor, MI, USA)
for generously providing the primary antibody for Ki-67 labeling.
Author contributions MJG-F was responsible for the study concept
and design with the contribution of CC-R and CB-H. CC-R and CB-H
conducted the experiments. CC-R analyzed the data. MJG-F revised
the data, plotted the figures and drafted the manuscript. All authors
have critically contributed and have approved the final version of the
manuscript for publication.
Funding Open Access funding provided thanks to the CRUE-CSIC
agreement with Springer Nature. This work was supported by 'Del-
egación del Gobierno para el Plan Nacional sobre Drogas' (2020/001,
Ministerio de Sanidad, Spain) to MJG-F; a pre-doctoral scholarship
(FPU2022-012-A; Conselleria de Fons Europeus, Universitat i Cultura
C.Colom-Rocha et al.
1 3
del Govern de les Illes Balears) to CC-R; and “TECH” from project
“TALENT PLUS Construint Salut, Generant Valor" (IdISBa, GOIB) to
CB-H. MJG-F and CC-R are members of RIAPAd (RD21/0009/0008;
ISCIII, Plan de Recuperación, Transformación y Resilencia,
NextGenerationEU).
Declarations
Conflict of interest None.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long
as you give appropriate credit to the original author(s) and the source,
provide a link to the Creative Commons licence, and indicate if changes
were made. The images or other third party material in this article are
included in the article's Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in
the article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
References
1. SAMHSA. National survey of drug use and health (NSDUH)
releases. substance abuse and mental health services administra-
tion (SAMSA), 2020. https:// www. samhsa. gov/ data/ relea se/ 2020-
natio nal- survey- drug- use- and- health- nsduh- relea ses. Accessed
July 15, 2022.
2. Gowin JL, Sloan ME, Stangl BL, Vatsalya V, Ramchandani VA.
Vulnerability for alcohol use disorder and rate of alcohol con-
sumption. Am J Psychiatry. 2017;174:1094–101.
3. Richter CP, Campbell KH. Alcohol taste thresholds and concen-
trations of solution preferred by rats. Science. 1940;91:507–8.
4. Crabbe JC, Harris RA, Koob GF. Preclinical studies of alcohol
binge drinking. Ann N Y Acad Sci. 2011;216:24–40.
5. Carnicella S, Ron D, Barak S. Intermittent ethanol access sched-
ule in rats as a preclinical model of alcohol abuse. Alcohol.
2014;48:243–52.
6. Becker HC. Positive relationship between the number of prior
ethanol withdrawal episodes and the severity of subsequent with-
drawal seizures. Psychopharmacology. 1994;116:26–32.
7. Duka T, Gentry J, Malcolm R, Ripley TL, Borlikova G, Stephens
DN, etal. Consequences of multiple withdrawals from alcohol.
Alcohol Clin Exp Res. 2004;28:233–46.
8. Bloch S, Holleran KM, Kash TL, Vazey EM, Rinker JA, Lebon-
ville CL, etal. Assessing negative affect in mice during abstinence
from alcohol drinking: limitations and future challenges. Alcohol.
2022;100:41–56.
9. Fu R, Gregor D, Peng Z, Li J, Bekker A, Ye J. Chronic intermittent
voluntary alcohol drinking induces hyperalgesia in Sprague-Daw-
ley rats. Int J Physiol Pathophysiol Pharmacol. 2015;7:136–44.
10. Coker CR, Aguilar EA, Snyder AE, Bingaman SS, Graziane NM,
Browning KN, etal. Access schedules mediate the impact of high
fat diet on ethanol intake and insulin and glucose function in mice.
Alcohol. 2020;86:45–56.
11. Becker JB, Koob GF. Sex differences in animal models: focus on
addiction. Pharmacol Rev. 2016;68:242–63.
12. Cailhol S, Mormede P. Sex and strain differences in etha-
nol drinking: effects of gonadectomy. Alcohol Clin Exp Res.
2001;25:594–9.
13. Dhaher R, McConnell KK, Rodd ZA, McBride WJ, Bell RL.
Daily patterns of ethanol drinking in adolescent and adult, male
and female, high alcohol drinking (HAD) replicate lines of rats.
Pharmacol Biochem Behav. 2012;102:540–8.
14. Priddy BM, Carmack SA, Thomas LC, Vendruscolo JC, Koob GF,
Vendruscolo LF. Sex, strain, and estrous cycle influences on alco-
hol drinking in rats. Pharmacol Biochem Behav. 2017;152:61–7.
15. Walker DW, Barnes DE, Zornetzer SF, Hunter BE, Kubanis P.
Neuronal loss in hippocampus induced by prolonged ethanol con-
sumption in rats. Science. 1980;209:711–3.
16. Morrisett RA, Swartzwelder HS. Attenuation of hippocam-
pal long-term potentiation by ethanol: a patch-clamp analy-
sis of glutamatergic and GABAergic mechanisms. J Neurosci.
1993;13:2264–72.
17. Sullivan EV, Marsh L, Mathalon DH, Lim KO, Pfefferbaum
A. Anterior hippocampal volume deficits in nonamnesic, aging
chronic alcoholics. Alcohol Clin Exp Res. 1995;19:110–22.
18. Beresford TP, Arciniegas DB, Alfers J, Clapp L, Martin B, Du Y,
etal. Hippocampus volume loss due to chronic heavy drinking.
Alcohol Clin Exp Res. 2006;30:1866–70.
19. Maynard ME, Barton EA, Robinson CR, Wooden JI, Leasure JL.
Sex differences in hippocampal damage, cognitive impairment,
and trophic factor expression in an animal model of an alcohol
use disorder. Brain Struct Funct. 2018;223:195–210.
20. McGrath EL, Gao J, Kuo YF, Dunn TJ, Ray MJ, Dineley KT,
etal. Spatial and sex-dependent responses of adult endogenous
neural stem cells to alcohol consumption. Stem Cell Reports.
2017;9:1916–30.
21. Richardson HN, Chan SH, Crawford EF, Lee YK, Funk CK, Koob
GF, etal. Permanent impairment of birth and survival of cortical
and hippocampal proliferating cells following excessive drinking
during alcohol dependence. Neurobiol Dis. 2009;36:1–10.
22. Mandyam CD, Koob GF. The addicted brain craves new neurons:
putative role for adult-born progenitors in promoting recovery.
Trends Neurosci. 2012;35:250–60.
23. Choi MR, Han JS, Jin YB, Lee SR, Choi IY, Lee H, etal. Dif-
ferential expression of microRNAs in the hippocampi of male
and female rodents after chronic alcohol administration. Biol Sex
Differ. 2020;11:65.
24. Barton EA, Baker C, Leasure JL. Investigation of sex differences
in the microglial response to binge ethanol and exercise. Brain
Sci. 2017;7:139.
25. Ramos-Miguel A, Álvaro-Bartolomé M, García-Fuster MJ,
García-Sevilla JA. Role of multifunctional FADD (Fas-Associated
Death Domain) adaptor in drug addiction. Addictions-from patho-
physiology to treatment. InTech Open, 2012. Belin David, Editor.
Chapter7:201–226. ISBN: 978–953–51–0783–5.
26. García-Fuster MJ, Álvaro-Bartolomé M, García-Sevilla JA. The
Fas Receptor/Fas-associated protein and cocaine. Neuropathology
of drug addictions and substance misuse, Volume 2: Stimulants,
club and dissociative drugs, hallucinogens, steroids, inhalants and
international aspects. Chapter6. Academic Press, 2016. Edited by
Victor R. Preedy.
27. García-Fuster MJ, Flagel SB, Mahmood ST, Mayo LM, Thomp-
son RC, Watson SJ, etal. Decreased proliferation of adult hip-
pocampal stem cells during cocaine withdrawal: possible role
of the cell fate regulator FADD. Neuropsychopharmacology.
2011;36:2303–17.
28. García-Cabrerizo R, Keller B, García-Fuster MJ. Hippocampal
cell fate regulation by chronic cocaine during periods of ado-
lescent vulnerability: consequences of cocaine exposure during
adolescence on behavioral despair in adulthood. Neuroscience.
2015;304:302–15.
29. García-Cabrerizo R, García-Fuster MJ. Chronic MDMA induces
neurochemical changes in the hippocampus of adolescent and
Evaluating signs ofhippocampal neurotoxicity induced byarevisited paradigm ofvoluntary…
1 3
young adult rats: down-regulation of apoptotic markers. Neuro-
toxicology. 2015;49:104–13.
30. Lagace DC, Benavides DR, Kansy JW, Mapelli M, Greengard P,
Bibb JA, etal. Cdk5 is essential for adult hippocampal neurogen-
esis. Proc Natl Acad Sci USA. 2008;105:18567–71.
31. Ledesma-Corvi S, García-Fuster MJ. Revisiting the antidepres-
sant-like effects of desipramine in male and female adult rats:
sex disparities in neurochemical correlates. Pharmacol Rep.
2022;74:626–36.
32. Reis KP, Heimfarth L, Pierozan P, Ferreira F, Loureiro SO, Fer-
nandes CG, etal. High postnatal susceptibility of hippocampal
cytoskeleton in response to ethanol exposure during pregnancy
and lactation. Alcohol. 2015;49:665–74.
33. Karoly HC, Skrzynski CJ, Moe EN, Bryan AD, Hutchison KE.
Exploring relationships between alcohol consumption, inflamma-
tion, and brain structure in a heavy drinking sample. Alcohol Clin
Exp Res. 2021;45:2256–70.
34. Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M,
Browne WJ, etal. Reporting animal research: explanation and
elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020;18:
e3000411.
35. Li J, Chen P, Han X, Zuo W, Mei Q, Bian EY, etal. Differences
between male and female rats in alcohol drinking, negative affects
and neuronal activity after acute and prolonged abstinence. Int J
Physiol Pathophysiol Pharmacol. 2019;11:163–76.
36. Beltz AM, Beery AK, Becker JB. Analysis of sex differences in
pre-clinical and clinical data sets. Neuropsychopharmacology.
2019;44:2155–8.
37. García-Fuster MJ, Perez JA, Clinton SM, Watson SJ, Akil H.
Impact of cocaine on adult hippocampal neurogenesis in an ani-
mal model of differential propensity to drug abuse. Eur J Neuro-
sci. 2010;31:79–89.
38. García-Cabrerizo R, García-Fuster MJ. Comparative effects
of amphetamine-like psychostimulants on rat hippocampal
cell genesis at different developmental ages. Neurotoxicology.
2016;56:29–39.
39. García-Cabrerizo R, Ledesma-Corvi S, Bis-Humbert C, García-
Fuster MJ. Sex differences in the antidepressant-like potential of
repeated electroconvulsive seizures in adolescent and adult rats:
regulation of the early stages of hippocampal neurogenesis. Eur
Neuropsychopharmacol. 2020;41:132–45.
40. Michel MC, Murphy TJ, Motulsky HJ. New author guidelines for
displaying data and reporting data analysis and statistical methods
in experimental biology. J Pharmacol Exp Ther. 2020;372:136–47.
41. Spanagel R. Animal models of addiction. Dialogues Clin Neuro-
sci. 2017;19:247–58.
42. Yagi S, Galea LAM. Sex differences in hippocampal cognition
and neurogenesis. Neuropsychopharmacology. 2019;44:200–13.
43. Yagi S, Splinter JEJ, Tai D, Wong S, Wen Y, Galea LAM. Sex
differences in maturation and attrition of adult neurogenesis in the
hippocampus. eNeuro. 2020;7:1–14.
44. Mahmoud R, Wainwright SR, Galea LAM. Sex hormones and
adult hippocampal neurogenesis: regulation, implications, and
potential mechanisms. Front Neuroendocrinol. 2016;41:129–52.
45. Castaneda F, Rosin-Steiner S. Low concentration of ethanol
induce apoptosis in HepG2 cells: role of various signal transduc-
tion pathways. Int J Med Sci. 2006;33:160–7.
46. Morio Y, Tsuji M, Inagaki M, Nakagawa M, Asaka Y, Oyamada
H, etal. Ethanol-induced apoptosis in human liver adenocarci-
noma cells (SK-Hep1): Fas- and mitochondria-mediated pathways
and interaction with MAPK signaling system. Toxicol InVitro.
2013;27:1820–9.
47. Rajgopal Y, Vemuri MC. Ethanol induced changes in cyclin-
dependent kinase-5 activity and its activators, P35, P67 (Munc-
18) in rat brain. Neurosci Lett. 2001;308:173–6.
48. Liu D, Li J, Rong X, Li J, Peng Y, Shen Q. Cdk5 promotes mito-
chondrial fission via Drp1 phosphorylation at S616 in chronic
ethanol exposure-induced cognitive impairment. Mol Neurobiol.
2022;59:7075–94.
49. Boronat MA, Olmos G, García-Sevilla JA. Attenuation of
tolerance to opioid-induced antinociception and protection
against morphine-induced decrease of neurofilament proteins
by idazoxan and other I2-imidazoline ligands. Br J Pharmacol.
1998;125:175–85.
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
... Against this background, we characterized the changes induced by an even earlier start of adolescent ethanol exposure at PND 28, as compared to the one previously depicted for cocaine initiation (vulnerability window starting on PND 33), as well as their combined impact on the effects emerging in adulthood, and while including both sexes in the study (Towers et al., 2023;Becker and Koob, 2016), since most of the data summarized above was done in male rodents. Particularly, we assessed affective-(i.e., behavioral despair and/or stress-coping mechanisms, anxiety-related behaviors, anhedonic-like response) and/or addictive-like behaviors [i.e., voluntary consumption: 20% ethanol two-bottle choice paradigm (Colom-Rocha et al., 2023)]. Then, we selected the worst outcome induced by prior adolescent drug exposure, to test whether two therapeutical interventions (cannabidiol or ketamine) would prevent the increased ethanol consumption emerging in adulthood (Yardley and Ray, 2017). ...
... The difference in sample sizes is related to the need of splitting the study in two independent waves while including enough controls in both of them. The design followed an intermittent access to 20% ethanol described to exert a steady consumption sustained over time, with higher overall doses for females (Colom-Rocha et al., 2023). In particular, this procedure allowed, on a weekly basis and for a total of 6 weeks, unlimited voluntary access to ethanol (20% ethanol vs. water) for 72 consecutive hours (3 days from Tuesdays to Thursdays, D3-D5, Figure 1) followed by a 4-day period with no ethanol access (access to two water-bottles: D6-D7, D1-D2) every week (i.e., a total of 18 ethanol sessions of 24 h). ...
... Sex effects are also reported in graphs (Dalla et al., 2024). Since expected sex-differences were initially hypothesized in affective-like responses (Jiménez-Romero et al., 2020; and ethanol consumption (Colom-Rocha et al., 2023), but also in the potential therapeutical response induced by cannabidiol (Gálvez-Melero et al., 2023) or ketamine (see main effects of Sex when performing two-way ANOVAs in Supplementary Table S1), male and female rats were analyzed separately through one-way ANOVAs. Multiple comparisons tests were performed for post hoc comparisons when appropriate (Dunnett's). ...
Article
Full-text available
Background Few studies have previously evaluated the long-term impact of initiating the combined use of alcohol and cocaine early-in-life during adolescence. Our preclinical study characterized changes in affective-like behavior and/or voluntary ethanol consumption emerging later on in adulthood induced by a prior adolescent drug exposure, as well as tested therapeutical interventions (i.e., cannabidiol or ketamine) to prevent the observed effects. Methods We performed three independent studies with male and female Sprague-Dawley rats, treated in adolescence (postnatal days, PND 29–38) with non-contingent paradigms of ethanol, cocaine, their combination or vehicle. Later on, adult rats were (1) scored for their affective-like state (forced-swim, elevated-plus maze, novelty-suppressed feeding, sucrose preference), (2) allowed to freely drink ethanol for 6 weeks (two-bottle choice), or (3) treated with cannabidiol or ketamine before given access to ethanol in adulthood. Results No signs of increased negative affect were observed in adulthood following the adolescent treatments. However, adolescent ethanol exposure was a risk-factor for later developing an increased voluntary ethanol consumption in adulthood, both for male and female rats. This risk was similar when ethanol was combined with adolescent cocaine exposure, since cocaine alone showed no effects on later ethanol intake. Finally, rats exposed to adolescent ethanol and pretreated in adulthood with cannabidiol (and/or ketamine, but just for females) reduced their ethanol voluntary consumption. Conclusion Our data provided two therapeutical options capable of preventing the impact of an early drug initiation during adolescence by decreasing voluntary ethanol consumption in adult rats
... Interestingly, adolescence is a period of critical brain development that appears to be highly conserved across species in terms of its neurobehavioral and physiological features. Similar to the stages observed in humans, early (10 to 13 years), middle (14 to 17 years), and late adolescence/young adulthood (18 to 21 years; [3][4]), in rodents, adolescence could be divided into early (postnatal day, PND [21][22][23][24][25][26][27][28][29][30][31][32][33][34], mid (PND 34-46) and late adolescence (PND 46-59; [7]). Therefore, the use of rodents provides a great preclinical model [5][6] with face and construct validity [7] in which to study particular windows of adolescent vulnerability to psychopathology and therapeutic strategies [8]. ...
... Against this background, we characterized the changes induced by adolescent ethanol exposure at an even earlier start (PND 28) than cocaine (vulnerability window starting on PND 33), in line with the patterns observed in young consumers, as well as their combined impact on the effects emerging in adulthood during prolonged withdrawal, and while including both sexes in the study [22][23], since most of the data summarized above was done in male rodents. Particularly, we assessed affective-(i.e., behavioral despair, anxiety-related behaviors, anhedonic-like response) and/or addictive-like behaviors (i.e., voluntary consumption: 20% ethanol two-bottle choice paradigm; [24]). Then, we selected the worst outcome induced by prior adolescent drug exposure, to test whether two therapeutical interventions (cannabidiol or ketamine) would prevent the increased ethanol consumption emerging in adulthood [25]. ...
... This provided 4 experimental groups/sex that only differed in adolescent drug exposure. The design followed an intermittent access to 20% ethanol described to exert a steady consumption sustained over time, with higher overall doses for females [24]. In particular, this procedure allowed, on a weekly basis and for a total of 6 weeks, unlimited voluntary access to ethanol (20% ethanol vs. water) for 72 consecutive hours (3 days from Tuesdays to Thursdays, D3-D5, Fig. 1) followed by a 4-day period of withdrawal (access to 2 water-bottles: D6-D7, D1-D2) every week (i.e., a total of 18 ethanol sessions of 24 h). ...
Preprint
Full-text available
Few studies have previously evaluated the long-term impact of initiating the combined use of alcohol and cocaine early-in-life during adolescence. Our preclinical study characterized changes in affective-like behavior and/or voluntary ethanol consumption emerging later on in adulthood during withdrawal and induced by adolescent drug exposure, as well as tested therapeutical interventions (i.e., cannabidiol or ketamine) to prevent the observed effects. We performed 3 independent studies with male and female Sprague-Dawley rats, treated in adolescence (postnatal days, PND 29–38) with ethanol, cocaine, their combination or vehicle. Following prolonged forced-withdrawal, adult rats were (1) scored for their affective-like state (forced-swim, elevated-plus maze, novelty-suppressed feeding, sucrose preference), (2) allowed to freely drink ethanol for 6 weeks (two-bottle choice), or (3) treated with cannabidiol or ketamine before given access to ethanol in adulthood. The results proved no signs of increased negative affect during withdrawal in adulthood following the adolescent treatments. However, adolescent ethanol exposure was a risk-factor for later developing an increased voluntary ethanol consumption in adulthood, both for male and female rats. This risk was similar when ethanol was combined with adolescent cocaine exposure, since cocaine alone showed no effects on later ethanol intake. Finally, rats exposed to adolescent ethanol and pretreated during forced-withdrawal with cannabidiol (and/or ketamine, but just for females) reduced ethanol voluntary consumption in adulthood. Our data provided two therapeutical options capable of preventing the impact of an early drug initiation during adolescence by decreasing voluntary ethanol consumption in adult rats.
... энцефалопатии, учитывающих в первую очередь нарушение пластичности нервной ткани в условиях нейротоксического влияния продуктов обмена этанола [2,5]. ...
Article
We studied the psychopharmacological effects of a NF-κB inhibitor, a stimulator of the functions of progenitor cells of the nervous tissue, under conditions of modeled ethanol-induced encephalopathy. The pharmacological agent improved indicators of the orientation and exploratory behavior and reproducibility of the conditioned passive avoidance reflex in experimental animals. These effects developed against the background of a significant increase in the content and proliferative activity of neural stem cells in the subventricular zone of the brain and intensification of their specialization. The results indicate the prospects of developing fundamentally new agents with regenerative activity based on NF-κB blockers for the treatment of alcoholic encephalopathy.
Article
Full-text available
Excessive alcohol consumption can lead to alterations in brain structure and function, even causing irreversible learning and memory disorders. The hippocampus is one of the most sensitive areas to alcohol neurotoxicity in the brain. Accumulating evidence indicates that mitochondrial dysfunction contributes to alcohol neurotoxicity. However, little is known about the underlying molecular mechanisms. In this study, we found that chronic exposure to ethanol caused abnormal mitochondrial fission/fusion and morphology by activating the mitochondrial fission protein dynamin-related protein 1 (Drp1) and upregulating Drp1 receptors, such as fission protein 1 (Fis1), mitochondrial dynamics protein of 49 kDa (Mid49), and mitochondrial fission factor (Mff), combined with decreasing optic atrophy 1 (Opa1) and mitochondrial fusion protein mitofusin 1 (Mfn1) levels. In addition, mitochondrial division inhibitor 1 (mdivi-1) abrogated ethanol-induced mitochondrial dysfunction and improved hippocampal synapses and cognitive function in ethanol-exposed mice. Chronic ethanol exposure also resulted in cyclin-dependent kinase 5 (Cdk5) overactivation, as shown by the increase in the levels of Cdk5 and its activator P25 in the hippocampus. Furthermore, a Cdk5/P25 inhibitor (roscovitine) or Cdk5 knockdown using small interfering RNA (LVi-Cdk5) exerted neuroprotection by inhibiting abnormal mitochondrial fission through Drp1 phosphorylation at Ser616 and mitochondrial translocation after chronic ethanol exposure. Taken together, the present study demonstrated that inhibition of aberrant Cdk5 activation attenuates hippocampal neuron injury and cognitive deficits induced by chronic exposure to ethanol through Drp1-mediated mitochondrial fission and mitochondrial dysfunction. Interfering with this pathway might serve as a potential therapeutic approach to prevent ethanol-induced neurotoxicity in the brain.
Article
Full-text available
Background The preclinical antidepressant-like characterization of desipramine relied almost exclusively in male rodents, with only a few contradictory reports done in females. Given that most experiments assessed a single dose and/or timepoint of analysis after-treatment, this study evaluated potential sex-differences in the length of the antidepressant-like response induced by different doses of desipramine as well as the molecular underpinnings driving the different responses by sex. Methods Male and female Sprague–Dawley rats were treated (i.p.) with 3 pulses of desipramine (5, 10 or 20 mg/kg) or vehicle (0.9% NaCl) within 24 h. The antidepressant-like effects were evaluated in the forced-swim test 1-h, 1- and 3-day post-treatment. The rate of cell proliferation and the regulation of key neuroplasticity markers (FADD, Cdk5, p35, p25) involved in antidepressant-like responses in the hippocampus were evaluated 1-h, 1-day and 5-day post-treatment. Results Desipramine induced similar antidepressant-like effects in male and female rats (effective doses of 10 and 20 mg/kg, with effects that lasted up to 1-day post-treatment), without altering the rate of cell proliferation. However, some sex-differences emerged when evaluating neuroplasticity markers in the hippocampus, while no changes were observed for female rats, desipramine regulated FADD, Cdk-5 and p25 in males in a way that suggested neuroprotective actions. Conclusions Our findings imply that while desipramine induced similar antidepressant-like responses for male and female rats, some differences emerged in the regulation of certain neuroplasticity markers, suggesting that distinctive molecular mechanisms might be participating in the therapeutic response of desipramine for both sexes.
Article
Full-text available
Background Chronic alcohol consumption is associated with structural brain changes and increased inflammatory signaling throughout the brain and body. Increased inflammation in the brain has been associated with structural damage. Recent studies have also shown that neurofilament light polypeptide (NfL) is released into the systemic circulation following neuronal damage. Although NfL has thus been proposed as a biomarker for neurodegenerative diseases, its connection to alcohol use disorder has not been explored. For this secondary data analysis, we proposed a conceptual model linking alcohol consumption, the pro‐inflammatory cytokine IL‐6, brain structure, and NfL in heavy drinking participants. Methods Of the 182 individuals enrolled in this study, 81 participants had usable data on gray matter (GM) thickness and 80 had usable data on white matter (WM) diffusivity. A subset of participants had NfL (n = 78) and IL‐6 (n = 117) data. An estimate of GM thickness was extracted from middle frontal brain regions using FreeSurfer. Estimated mean WM diffusivity values were extracted from Tract Based Spatial Statistics. NfL and IL‐6 were measured in blood. Regression models were used to test individual linkages in the conceptual model. Based on significant regression results, we created a simplified conceptual model, which we tested using path analysis. Results In regressions, negative relationships emerged between GM and both drinks per drinking day (DPDD) (p = 0.018) and NfL (p = 0.004). A positive relationship emerged between WM diffusivity and DPDD (p = 0.033). IL‐6 was not significantly associated with alcohol use, GM or WM. The final path model demonstrated adequate fit to the data and showed significant, negative associations between DPDD and middle frontal gyrus (MFG) thickness, and between MFG thickness and NfL, but the association between DPDD and NfL was not significant. Conclusions This is the first study to show that heavy drinking is associated with lower GM thickness and higher WM diffusivity and that lower GM thickness is associated with higher circulating NfL. The analyses also show that the effects of drinking do not involve the pro‐inflammatory cytokine IL‐6.
Article
Full-text available
Age and sex are critical factors for the diagnosis and treatment of major depression, since there is a well-known age-by-sex difference in the prevalence of major depression (being females the most vulnerable ones) and in antidepressant efficacy (being adolescence a less responsive period than adulthood). Although the induction of electroconvulsive seizures (ECS) is a very old technique in humans, there is not much evidence reporting sex- and age-specific aspects of this treatment. The present study evaluated the antidepressant- and neurogenic-like potential of repeated ECS across time in adolescent and adult rats (naïve or in a model of early life stress capable of mimicking a pro-depressive phenotype), while including a sex perspective. The main results demonstrated age- and sex-specific differences in the antidepressant-like potential of repeated ECS, since it worked when administered during adolescence or adulthood in male rats (although with a shorter length in adolescence), while in females rendered deleterious during adolescence and ineffective in adulthood. Yet, repeated ECS increased cell proliferation and vastly boosted young neuronal survival in a time-dependent manner for both sexes and independently of age. Moreover, pharmacological inhibition of basal cell proliferation prevented the antidepressant-like effect induced by repeated ECS in male rats, but only partially blocked the very robust increase in the initial cell markers of hippocampal neurogenesis. Overall, the present results suggest that the induction of the early phases of neurogenesis by ECS, besides having a role in mediating its antidepressant-like effect, might participate in some other neuroplastic actions, opening the path for future studies.
Article
Full-text available
Background Women are more vulnerable than men to the neurotoxicity and severe brain damage caused by chronic heavy alcohol use. In addition, brain damage due to chronic heavy alcohol use may be associated with sex-dependent epigenetic modifications. This study aimed to identify microRNAs (miRNAs) and their target genes that are differentially expressed in the hippocampi of male and female animal models in response to alcohol. Methods After chronic alcohol administration (3~3.5 g/kg/day) in male (control, n = 10; alcohol, n = 12) or female (control, n = 10; alcohol, n = 12) Sprague-Dawley rats for 6 weeks, we measured body weights and doublecortin (DCX; a neurogenesis marker) concentrations and analyzed up- or downregulated miRNAs using GeneChip miRNA 4.0 arrays. The differentially expressed miRNAs and their putative target genes were validated by RT-qPCR. Results Alcohol attenuated body weight gain only in the male group. On the other hand, alcohol led to increased serum AST in female rats and decreased serum total cholesterol concentrations in male rats. The expression of DCX was significantly reduced in the hippocampi of male alcohol-treated rats. Nine miRNAs were significantly up- or downregulated in male alcohol-treated rats, including upregulation of miR-125a-3p, let-7a-5p, and miR-3541, and downregulation of their target genes ( Prdm5 , Suv39h1 , Ptprz1 , Mapk9 , Ing4 , Wt1 , Nkx3-1 , Dab2ip , Rnf152 , Ripk1 , Lin28a , Apbb3 , Nras , and Acvr1c ). On the other hand, 7 miRNAs were significantly up- or downregulated in alcohol-treated female rats, including downregulation of miR-881-3p and miR-504 and upregulation of their target genes ( Naa50 , Clock , Cbfb , Arih1 , Ube2g1 , and Gng7 ). Conclusions These results suggest that chronic heavy alcohol use produces sex-dependent effects on neurogenesis and miRNA expression in the hippocampus and that sex differences should be considered when developing miRNA biomarkers to diagnose or treat alcoholics.
Article
Full-text available
Improving the reproducibility of biomedical research is a major challenge. Transparent and accurate reporting is vital to this process; it allows readers to assess the reliability of the findings and repeat or build upon the work of other researchers. The ARRIVE guidelines (Animal Research: Reporting In Vivo Experiments) were developed in 2010 to help authors and journals identify the minimum information necessary to report in publications describing in vivo experiments. Despite widespread endorsement by the scientific community, the impact of ARRIVE on the transparency of reporting in animal research publications has been limited. We have revised the ARRIVE guidelines to update them and facilitate their use in practice. The revised guidelines are published alongside this paper. This explanation and elaboration document was developed as part of the revision. It provides further information about each of the 21 items in ARRIVE 2.0, including the rationale and supporting evidence for their inclusion in the guidelines, elaboration of details to report, and examples of good reporting from the published literature. This document also covers advice and best practice in the design and conduct of animal studies to support researchers in improving standards from the start of the experimental design process through to publication.
Article
Full-text available
Sex differences exist in the regulation of adult neurogenesis in the hippocampus in response to hormones and cognitive training. Here we investigated the trajectory and maturation rate of adult-born neurons in the dentate gyrus (DG) of male and female rats. Sprague-Dawley rats were perfused two hours, 24 hours, one, two or three weeks after BrdU injection, a DNA synthesis marker that labels dividing progenitor cells and their progeny. Adult-born neurons (BrdU/NeuN-ir) matured faster in males compared to females. Males had a greater density of neural stem cells (Sox2-ir) in the dorsal, but not in the ventral, DG and had higher levels of cell proliferation (Ki67-ir) than non-proestrous females. However, males showed a greater reduction in neurogenesis between one and two weeks after mitosis, whereas females showed similar levels of neurogenesis throughout the weeks. The faster maturation and greater attrition of new neurons in males compared to females suggests greater potential for neurogenesis to respond to external stimuli in males and emphasizes the importance of studying sex on adult hippocampal neurogenesis.Significance Statement Previously studies examining the characteristics of adult-born neurons in the dentate gyrus have used almost exclusively male subjects. Researchers have assumed the two sexes have a similar maturation and attrition of new neurons in the dentate gyrus of adults. However, this study highlights notable sex differences in the attrition, maturation rate and potential of neurogenesis in the adult hippocampus that has significant implications for the field of neuroplasticity. These findings are important in understanding the relevance of sex differences in the regulation of neurogenesis in the hippocampus in response to stimuli or experience and may have consequences for our understanding of diseases that involve neurodegeneration of the hippocampus, particularly those that involve sex differences, such as Alzheimer's disease and depression.
Article
Full-text available
The American Society for Pharmacology and Experimental Therapeutics has revised the Instructions to Authors for Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, and Molecular Pharmacology These revisions relate to data analysis (including statistical analysis) and reporting but do not tell investigators how to design and perform their experiments. Their overall focus is on greater granularity in the description of what has been done and found. Key recommendations include the need to differentiate between preplanned, hypothesis-testing, and exploratory experiments or studies; explanations of whether key elements of study design, such as sample size and choice of specific statistical tests, had been specified before any data were obtained or adapted thereafter; and explanation of whether any outliers (data points or entire experiments) were eliminated and when the rules for doing so had been defined. Variability should be described by S.D. or interquartile range, and precision should be described by confidence intervals; S.E. should not be used. P values should be used sparingly; in most cases, reporting differences or ratios (effect sizes) with their confidence intervals will be preferred. Depiction of data in figures should provide as much granularity as possible, e.g., by replacing bar graphs with scatter plots wherever feasible and violin or box-and-whisker plots when not. This editorial explains the revisions and the underlying scientific rationale. We believe that these revised guidelines will lead to a less biased and more transparent reporting of research findings.
Article
Alcohol use disorder (AUD) is frequently comorbid with mood disorders, and these co-occurring neuropsychiatric disorders contribute to the development and maintenance of alcohol dependence and relapse. In preclinical models, mice chronically exposed to alcohol display anxiety-like and depressive-like behaviors during acute withdrawal and protracted abstinence. However, in total, results from studies using voluntary alcohol drinking paradigms show variable behavioral outcomes in assays measuring negative affective behaviors. Thus, the main objective of this review is to summarize the literature on the variability of negative affective behaviors in mice after chronic alcohol exposure. We compare the behavioral phenotypes that emerge during abstinence across different exposure models, including models of alcohol and stress interactions. The complicated outcomes from these studies highlight the difficulties of assessing negative affective behaviors in mouse models designed for the study of AUD. We discuss new behavioral assays, comprehensive platforms, and unbiased machine-learning algorithms as promising approaches to better understand the interaction between alcohol and negative affect in mice. New data-driven approaches in the understanding of mouse behavior hold promise for improving the identification of mechanisms, cell subtypes, and neurocircuits that mediate negative affect. In turn, improving our understanding of the neurobehavioral basis of alcohol-associated negative affect will provide a platform to test hypotheses in mouse models that aim to improve the development of more effective strategies for treating individuals with AUD and co-occurring mood disorders.
Article
Alcoholism and high fat diet (HFD)-induced obesity individually promote insulin resistance and glucose intolerance in clinical populations, increasing risk for metabolic diseases. HFD can also stimulate alcohol intake in short term clinical studies. Unfortunately, there is currently a disconnect between animal models and the clinical findings as animal studies typically show that HFD decreases ethanol intake while ethanol intake mitigates HFD-induced effects on insulin and glucose dysfunction. However, most previous animal studies utilized forced or continuous HFD and/or ethanol. In three experiments we sought to determine if HFD (HFD=60% calories from fat) vs control diet (Chow=16% fat) alters voluntary two-bottle choice ethanol intake in male C57Bl/6J mice given differing access schedules for 6-7 weeks and assessed resultant impact on metabolic function via insulin and glucose tolerance tests. Experiment 1: Unlimited Access Ethanol+HFD (UAE+HFD; n=15; 10% ethanol v/v, ad libitum diet and ethanol) or UAE+Chow (n=15). Experiment 2: Limited Access Ethanol+HFD (LAE+HFD; n=15; ethanol= 4 hrs/d; 3 d/wk, ad libitum diet) or LAE+Chow (n=15) with increasing ethanol concentrations (10%, 15%, 20%). Experiment 3: Intermittent HFD with limited access to ethanol (iHFD-E; HFD= single 24 hr session/week; ethanol= 4hrs/d; 4 d/wk) (n=10). UAE+HFD mice consumed significantly less ethanol and were insulin resistant and hyperglycemic compared with UAE+Chow mice. LAE+HFD mice consumed ethanol similarly to LAE+Chow mice, but exhibited hyperglycemia, insulin resistance, and glucose intolerance. iHFD-E mice displayed binge eating-like behaviors and consumed significantly more ethanol than mice given ad libitum chow or HFD. iHFD-E mice did not have significantly altered body composition, but developed insulin insensitivity and glucose intolerance. These findings suggest access schedules influence HFD effects on ethanol consumption and resultant metabolic dysfunction, ethanol intake does not improve HFD-induced metabolic dysfunction, and binge eating-like behaviors can transfer to binge drinking behaviors.